GUJARAT TERCE LABORATORIES LTD Share Price

GUJARAT TERCE LABORATORIES LTD Share Price

BSE: 524314
|
Pharmaceuticals
|
S Cap
₹ 37.78
+0.00 (0.00%)
1D
Last updated 23 Sep, 2026, 15:24 IST

GUJARAT TERCE LABORATORIES LTD Share Price Today

As of 24 Sep 2026, GUJARAT TERCE LABORATORIES LTD share price is ₹37.78. The stock opened at ₹37.78, compared to its previous close of ₹37.78. During today's trading session, GUJARAT TERCE LABORATORIES LTD share price moved in the range of ₹36.00 to ₹37.78, with an average price of ₹36.89 for the day. Looking at its last 52-week, the stock has touched a low of ₹29.00 and a high of ₹59.78.

₹36.00
0.00% up today
₹37.78
1D LOW
1D HIGH

GUJARAT TERCE LABORATORIES LTD Returns Calculator

Circuit
L
H
₹30.23
₹45.33
52-week
L
H
₹29.00
₹59.78

About GUJARAT TERCE LABORATORIES LTD

GUJARAT TERCE LABORATORIES LTD Share Price
ISIN
INE499G01013
Sector Market Cap
₹ 29.44 Cr

Gujarat Terce Laboratories Limited is an India-based integrated pharmaceutical company. The Company is engaged in the development, manufacturing, marketing and distribution of medicines and healthcare products. Its product basket includes branded as well as generic formulations offering solutions for disease prevention and control. It offers a range of products under 52 brands, totaling 135 items approximately, and its portfolio covers 10 therapeutic categories such as respiratory, gynecology, antibiotics, pain therapy, gastrology, nutraceutical, and ayurvedic therapies. The Company’s brands include Acolate, Codimol, Terflora Z, Thyter, Tynol, Moxxil and Vitfol, among others. It caters to both domestic and international markets. The manufacturing facility of the Company is located at Chhatral in Gandhinagar, Gujarat.

GUJARAT TERCE LABORATORIES LTD Financial Highlights

  • Revenue: GUJARAT TERCE LABORATORIES LTD reported revenue of ₹25.98 crore in FY21 vs ₹37.83 crore in FY20. It showed a decrease of 31.32% on a yearly basis.
  • Operating Profit: GUJARAT TERCE LABORATORIES LTD reported an operating loss of ₹2.53 crore in FY21 vs ₹0.44 crore in FY20. It showed a decrease of 675.00% on a year-on-year basis.
  • Net Profit: GUJARAT TERCE LABORATORIES LTD reported a net loss of ₹2.52 crore in FY21 vs ₹0.28 crore in FY20. It showed a decrease of 1,000.00% on a yearly basis.

GUJARAT TERCE LABORATORIES LTD Quarterly Result Highlights

  • GUJARAT TERCE LABORATORIES LTD reported revenue of ₹10.21 crore in Sep 2021, compared with ₹10.01 crore in Jun 2021, representing an increase of 2.00% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT TERCE LABORATORIES LTD reported an operating profit of ₹0.45 crore in Sep 2021, compared with ₹1.60 crore in Jun 2021, representing a decrease of 71.88% on a quarter-on-quarter (QoQ) basis.
  • GUJARAT TERCE LABORATORIES LTD reported a profit of ₹0.45 crore in Sep 2021, compared with ₹1.60 crore in Jun 2021, reflecting a decrease of 71.88% on a QoQ basis.

Data Source: BSE, Company announcements

Securities shown are illustrative, not recommendations. Past performance does not guarantee future results.

Know more
Promoters
40.03%
FII
0.00%
Other DII
0.00%
Retail and other
59.97%
Mutual funds
0.00%
Foreign Institutional Investor (FII)
FII shareholding by period
Sep 20250.00%
Dec 20250.00%
Mar 20260.00%
Jun 20260.00%
Mkt Cap Cr
29.40
P/E
14.08
P/B
3.02
ROE
25.62%
D/E
0.13
ROCE
29.29%
Div. Yield
0.00%
EPS(TTM)
2.92
Turnover
1.86
EV/EBITDA
7.85
Net Margin
5.16%
Op. Margin
8.51%
ROA
8.47%
Quick Ratio
0.98
Curr. Ratio
1.49
Based on fundamentals, this stock's
Step 5 of 5
Performance
Excellent
Guj. Terce Labs. outperforming all market indices
Step 1 of 5
Valuation
Overvalued
Guj. Terce Labs. appears overvalued compared to its peers
Step 2 of 5
Earnings
Poor
Guj. Terce Labs. earnings have been degrowing
Peer Comparison
Peer comparison — key ratios
NameMkt Cap CrP/EP/BROED/EROCEBook ValueDiv. YieldTurnoverEPS(TTM)
Sun Pharmaceutical Industries4,42,437.0036.515.2913.74%0.6117.33%93.240.87%0.4810.90
Divis Laboratories2,48,054.0084.8114.8015.32%0.0019.56%629.490.32%0.5598.19
Torrent Pharmaceuticals1,89,842.0088.0622.5725.49%1.6913.85%222.760.68%0.4958.70
Zydus Lifesciences1,15,810.0025.224.2718.59%0.3117.35%237.300.09%0.3335.38
Cipla1,11,565.0033.223.2411.27%0.0014.95%423.360.94%0.4543.52
Laurus Labs1,08,338.0099.3620.4416.77%0.4016.14%97.200.10%0.6713.72
Mankind Pharma1,01,712.0049.536.2811.74%0.3413.13%396.980.04%0.4449.37
Dr. Reddy's Laboratories1,01,163.0031.782.6611.07%0.1812.54%377.950.66%0.4138.68
Aurobindo Pharma97,641.6026.312.589.25%0.1911.76%394.820.24%0.3841.58
Lupin96,950.0017.474.3223.76%0.0424.88%658.960.85%0.57129.18

Auto-generated based on historical fundamentals; not a recommendation to buy/sell.

GUJARAT TERCE LABORATORIES LTD Financials

Full statement

Income Statement · Consolidated

Income Statement · Consolidated — all values in INR Crore
ParticularsMar 2019Mar 2020Mar 2021
Revenue31.3537.8325.98
Operating profit0.350.44-2.53
Net profit0.430.28-2.52

Income Statement · Standalone

Income Statement · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Revenue₹47.47₹50.20₹47.97₹46.78
Other Income₹0.34₹0.31₹0.32₹0.35
Total Revenue₹47.81₹50.50₹48.30₹47.14
Total Expenses₹44.33₹47.11₹47.75₹50.03
Profit Before Tax₹3.03₹3.39₹0.54-₹2.89
Tax₹0.83₹4.37₹0.30-₹1.22
Profit After Tax₹2.20-₹0.98₹0.24-₹1.67
EPS - Basic₹2.92-₹1.32₹1.26-₹2.25
EPS - Diluted₹2.92-₹1.26₹1.26-₹2.25

Cash Flow · Standalone

Cash Flow · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Profit before tax₹3.03₹3.39₹0.54-₹2.89
Income before WC changes₹3.41₹3.92₹1.31-₹1.88
Change in Assets₹0.49₹0.40₹3.07-₹0.02
Change in Liabilities-₹2.18-₹1.18-₹1.78₹1.96
Change in WC-₹1.69-₹0.78₹1.29₹1.94
Cash flow from Operations₹1.71₹3.06₹2.60₹0.03
Cash flow from Investing-₹0.11₹0.46-₹0.46₹0.62
Cash flow from Financing₹0.47-₹2.83-₹4.08-₹0.12
Total Cash Flow₹2.08₹0.69-₹1.94₹0.52
Cash (Start of the year)₹0.78₹0.09₹2.03₹1.51
Cash (End of the year)₹2.86₹0.78₹0.09₹2.03

Balance Sheet · Standalone

Balance Sheet · Standalone — all values in INR Crore
ParticularsMar 2026Mar 2025Mar 2024Mar 2023
Non-Current Assets₹10.14₹10.80₹12.05₹12.48
Current Assets₹14.41₹12.02₹11.22₹16.05
Total Assets₹24.55₹22.83₹23.27₹28.53
Current Liabilities₹10.95₹12.64₹12.14₹16.61
Net Current Asset₹3.46-₹0.62-₹0.92-₹0.56
Non-Current Liabilities₹3.88₹3.71₹4.03₹5.06
Equity Capital₹9.73₹6.48₹7.11₹6.86
Total Equity & Liabilities₹24.55₹22.83₹23.27₹28.53
* All values are in INR Crore
Qty
Bid
0
0
0
0
0
0
0
0
0
0
Ask
Qty
0
0
0
0
0
0
0
0
0
0
Bid Total: 0
Ask Total: 0
Buy orders: 0%
Sell orders: 0%
Bearish
2
Neutral
6
Bullish
0
Slightly Bearish
by SEBI experts
Expert Pick
EXPPICK
Stop-loss
Entry price
Target
Indicator
Value
Verdict
RSI (14)
46.63
Neutral
ATR (14)
3.14
Neutral
STOCH(9,6)
36.93
Neutral
STOCH RSI (14)
23.65
Neutral
ADX(9)
31.6
Bearish
UO(9)
49.59
Neutral
ROC(12)
-7.15
Bearish
WillR(14)
-63.07
Neutral
Period
Simple value
Exponential vaue
5D
37.37
37.92
10D
39.03
38.48
20D
39.13
38.7
50D
37.92
38.01
100D
36.38
37.71
Volume trend — traded volume by day
23 Sep0L
22 Sep0L
21 Sep0L
18 Sep0L
17 Sep0L
Average0L

Technical indicators used here are for indicative purposes only. Kindly do not treat it as an investment or trading advice

Compare against other stocks
GUJARAT TERCE LABORATORIES LTD Share Price
GUJARAT TERCE LABORATORIES LTD
Pharmaceuticals
Add Stock
Add Another

GUJARAT TERCE LABORATORIES LTD Share Price FAQs

GUJARAT TERCE LABORATORIES LTD share price data is sourced from NSE/BSE and may be delayed. It is displayed for informational purposes only and does not constitute investment advice or a recommendation to buy or sell.

Trusted by 2 Crore+ Indians for their wealth-building needs. SEBI Registered Broker. SEBI Reg No. INZ000315837